People ask this question for different reasons. Some are trying to understand why addiction has run through their family across multiple generations. The question carries weight.
The honest answer is: genetics are a significant factor – research consistently estimates they account for 40 to 60 percent of a person’s risk for developing an addiction – and they are not the whole story. Understanding both parts of that answer matters more than either one alone.
What the Research Has Found
The genetic contribution to addiction risk is one of the better-documented findings in behavioral health research, established over decades of twin studies, family studies, and, more recently, genome-wide association studies.
Twin studies are the foundational evidence. Identical twins, who share nearly 100 percent of their genetic material, have substantially higher rates of concordance for addiction than fraternal twins, who share about 50 percent. That pattern holds across substances and across study populations, and it points clearly to a genetic component that is not explained by shared environment alone.
More recent research has identified specific genes associated with elevated addiction risk. The DRD2 gene, which codes for a dopamine receptor, has been linked to higher susceptibility for alcohol and stimulant use disorders – likely because variations in this gene affect how strongly the brain’s reward system responds to substances. The OPRM1 gene influences opioid receptor function and is associated with differences in how people experience both the effects of opioids and the severity of withdrawal. GABRA2, which affects GABA receptor activity, is associated with alcohol use disorder risk.
What these findings describe is not a gene that causes addiction. They describe gene variants that affect how the reward system, pain system, or stress response system functions – and that make some people’s brains more reactive to substances than others. That difference in reactivity is meaningful, but it does not operate in isolation.
Genetics vs. Heredity: What’s the Difference?
These two terms are often used interchangeably, but the distinction matters for how someone thinks about their own risk.
Genetics refers specifically to the gene variants you carry – the sequences of DNA inherited from your biological parents that influence how your body and brain function. Heredity is a broader concept: the pattern of traits, tendencies, and vulnerabilities that pass through families. Heredity includes genetics, but it also includes learned behaviors, modeled coping patterns, family environment, and the intergenerational transmission of trauma.
A child who grows up watching a parent manage stress, emotion, or physical pain with substances learns something about what substances are for – regardless of whether they also inherited the genetic variants associated with reward system reactivity. In most families with multigenerational substance use, both genetic and environmental factors are present and interacting, and separating them cleanly is rarely possible.
Environmental Factors That Interact with Genetic Risk
Genetic risk does not unfold in a vacuum. The research on gene-environment interaction is consistent: the same genetic variants produce very different outcomes depending on what someone’s environment looks like.
Early trauma and adverse childhood experiences (ACEs) are among the strongest environmental predictors of addiction, and they interact with genetic vulnerability in documented ways. People with both genetic risk and high ACE scores have substantially higher lifetime rates of substance use disorder than people with either factor alone.
Early exposure to substances – whether through experimentation in adolescence or through a household where substances were present – has a meaningful effect on risk, particularly for people who are genetically predisposed toward stronger reward responses. The earlier the first use, the higher the risk, a relationship that holds across substances and across studies.
Mental health history is closely tied to addiction risk, and the relationship runs in both directions: mental health conditions increase the likelihood of substance use, and substance use increases the likelihood of mental health conditions. Many of the genes associated with addiction risk are also associated with elevated risk for depression, anxiety, and other psychiatric conditions – suggesting that what is inherited is, in some cases, a broader vulnerability to dysregulation rather than a specific predisposition toward any one outcome.
Social environment – who someone spends time with, what norms their peer group models, and what stressors they face – shapes whether genetic risk translates into actual use patterns.
What Family History Actually Means for Your Risk
Having a parent or sibling with a substance use disorder can significantly increase your risk of developing one. Depending on the substance and research, that risk may double or triple. That increase matters, but it does not determine your future.
It helps to think of family history as important clinical information. During an intake assessment, providers often ask about substance use patterns within your family. This information helps them better understand your individual risk factors. It can also guide decisions about monitoring, prevention, and early intervention. However, family history represents only one part of a comprehensive assessment. It does not determine whether someone will develop an addiction or how treatment will unfold.
Families often struggle to talk openly about addiction. Some describe substance use as a personality problem, moral failure, or private source of shame. These beliefs can prevent important conversations about patterns that may affect other family members. Without those conversations, people may overlook their own risk factors or early warning signs. They may also wait longer to seek help or discuss their concerns with a healthcare provider. Talking openly about family history can help people recognize risks earlier and make more informed decisions about their health.
Can You Test Your Genes for Addiction Risk?
Direct-to-consumer genetic testing has made questions about addiction risk more practical. However, these tests have important limits.
Some tests identify gene variants linked to a higher risk of addiction. These may include variations in genes such as DRD2 and OPRM1. However, these variants cannot determine whether someone will develop an addiction. They also cannot predict how severe an addiction might become.
Genetic variants indicate possible risk, not a certain outcome. Someone may carry several higher-risk variants and never develop a substance use disorder. Another person may have no identified variants and still develop one.
Addiction treatment providers do not typically include genetic testing in a standard clinical assessment. The results usually do not change the information clinicians need to evaluate addiction risk and treatment needs.
Genetic information can also raise complex questions about privacy, insurance, employment, and family relationships. These concerns make careful interpretation especially important.
Instead, clinicians rely on a comprehensive assessment to understand each person’s situation. They review substance use, mental health, family history, trauma, and current functioning. They also examine the patterns of substance use that led someone to seek treatment.
What This Means If You’re Already Struggling
Genetic risk is sometimes used – consciously or not – as a reason why someone cannot get better. The logic runs: it is in my genes, so it is who I am, so treatment will not work. That is not what the research supports.
Evidence-based treatment for substance use disorder works across genetic profiles. What genetics may affect is which approaches are most helpful, how certain medications work, and what the biological component of cravings looks and feels like – all of which a good clinical assessment can account for. The inheritance is not the ceiling.
If you or someone you care about is dealing with addiction, residential treatment in Indiana offers an individualized inpatient approach that addresses both the substance use and the co-occurring mental health and trauma factors that so frequently accompany it.
Getting Help at Ladoga Recovery
Ladoga Recovery provides inpatient residential treatment for substance use disorder in Indiana. We accept most major insurance plans and Medicaid. Every treatment plan is individualized – built around a clinical assessment that takes the full picture into account, including family history, mental health history, and the specific nature of what someone is dealing with.
Verify your insurance coverage online or call us directly. Whether you are ready to start or just trying to understand what your options look like, that first conversation is a reasonable place to begin.
For those whose question about genetics comes from watching someone they love struggle to get help, the post on what to do when a loved one refuses to get help for addiction addresses that specific situation.
For a broader look at the levels of care available, the levels of care for addiction treatment in Indiana page covers what each stage involves and how people move through the continuum.
